FORA Capital LLC bought a new position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 26,567 shares of the medical instruments supplier's stock, valued at approximately $719,000.
Other institutional investors have also recently added to or reduced their stakes in the company. Brooklyn Investment Group bought a new position in shares of DENTSPLY SIRONA during the third quarter worth about $77,000. FMR LLC lifted its position in shares of DENTSPLY SIRONA by 5.1% in the 3rd quarter. FMR LLC now owns 9,056,774 shares of the medical instruments supplier's stock worth $245,076,000 after purchasing an additional 436,031 shares during the period. QVIDTVM Management LLC raised its position in shares of DENTSPLY SIRONA by 75.8% in the 3rd quarter. QVIDTVM Management LLC now owns 458,866 shares of the medical instruments supplier's stock worth $12,417,000 after acquiring an additional 197,803 shares in the last quarter. Cerity Partners LLC bought a new stake in DENTSPLY SIRONA in the third quarter worth approximately $482,000. Finally, Raymond James Trust N.A. lifted its position in shares of DENTSPLY SIRONA by 37.7% during the 3rd quarter. Raymond James Trust N.A. now owns 13,299 shares of the medical instruments supplier's stock valued at $360,000 after acquiring an additional 3,641 shares during the period. 95.70% of the stock is owned by institutional investors.
DENTSPLY SIRONA Price Performance
Shares of XRAY traded up $0.01 during mid-day trading on Friday, reaching $19.65. 1,289,235 shares of the stock traded hands, compared to its average volume of 3,119,723. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. DENTSPLY SIRONA Inc. has a 1 year low of $17.21 and a 1 year high of $37.60. The company has a market cap of $3.91 billion, a price-to-earnings ratio of -9.49, a price-to-earnings-growth ratio of 1.93 and a beta of 1.02. The firm has a fifty day moving average price of $22.69 and a 200 day moving average price of $24.85.
DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last announced its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.48 by $0.02. The company had revenue of $951.00 million during the quarter, compared to analysts' expectations of $939.10 million. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The firm's revenue was up .4% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.49 EPS. As a group, equities research analysts predict that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.
Analyst Ratings Changes
XRAY has been the subject of several recent research reports. Leerink Partners downgraded DENTSPLY SIRONA from an "outperform" rating to a "market perform" rating in a report on Thursday, November 7th. Evercore ISI decreased their target price on DENTSPLY SIRONA from $29.00 to $27.00 and set an "outperform" rating for the company in a research report on Tuesday, October 8th. Robert W. Baird lowered their price target on shares of DENTSPLY SIRONA from $31.00 to $24.00 and set a "neutral" rating on the stock in a research report on Friday, November 8th. StockNews.com downgraded shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a report on Tuesday, November 19th. Finally, Needham & Company LLC lowered their target price on shares of DENTSPLY SIRONA from $34.00 to $29.00 and set a "buy" rating on the stock in a report on Friday, October 25th. Seven analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. According to MarketBeat, DENTSPLY SIRONA presently has a consensus rating of "Hold" and an average price target of $29.50.
Get Our Latest Stock Analysis on XRAY
DENTSPLY SIRONA Profile
(
Free Report)
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
See Also
Before you consider DENTSPLY SIRONA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.
While DENTSPLY SIRONA currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.